PISCATAWAY, N.J.–(BUSINESS WIRE)–Genscript Biotech Corporation, the number one global provider of gene synthesis services and a strong player in synthetic biology, ended 2015 with a successful IPO on the Hong Kong exchange.
Source:: feeds.businesswire.com/click.phdo?i=45d8493952397c342b0b4a4412485c11
Related posts:
Fantex Series Michael Brockers Convertible Tracking Stock Begins Trading at Fantex.com
Conkwest Files Registration Statement for Proposed Initial Public Offering
Gores Holdings, Inc. Announces Pricing of $350,000,000 Initial Public Offering
NovoCure Limited Announces Closing of Initial Public Offering
